Relationship of genetic variation in genes encoding apolipoprotein A-IV, scavenger receptor BI, HMG-CoA reductase, CETP and apolipoprotein E with cholesterol metabolism and the response to plant stanol ester consumption

European Journal of Clinical Investigation

Volumn 32, Issue 4, 2002, Pages 242-250

  Plat, Jogchum ^a   Mensink, R P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cholesterol; Coronary heart disease; Lathosterol; Lipoproteins; Plant sterol; Polymorphism; Sitostanol

Indexed keywords

APOLIPOPROTEIN A4; APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SCAVENGER RECEPTOR; STANOL ESTER;

ADULT; ARTICLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD36; APOLIPOPROTEINS A; APOLIPOPROTEINS E; CARRIER PROTEINS; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, LDL; DIET; FEMALE; GLYCOPROTEINS; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; LIPIDS; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MEMBRANE PROTEINS; PHYTOSTEROLS; POLYMORPHISM, GENETIC; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOPROTEIN; RECEPTORS, SCAVENGER; SCAVENGER RECEPTORS, CLASS B; SITOSTEROLS; VARIATION (GENETICS);

EID: 0036995167     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.00982.x     Document Type: Article

References (42)

1. Katan MB, Beynen AC, de Vries JHM, Nobels A. Existence of consistent hypo- and hyperresponders to dietary cholesterol in man. Am J Epidemiol 1986;123:221-34.
2. Ehnholm C, Lukka M, Kuusi T, Nikkila E, Uterman G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res 1986;27:227-35.
3. Weintraub MS, Eisenberg S, Breslow JL. Dietary fat clearance im normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 1987;80:1571-7.
4. Kesäniemi YA, Ehnholm C, Miettinen TA. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 1987;80:578-81.
5. Utermann G. Apolipoprotein E polymorphism in health and disease. Am Heart J 1987;113:433-40.
6. Boerwinkle E, Brown SA, Rohrbach K, Gotto AM, Patch W. Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol. Am J Hum Genet 1991;49:1145-54.
7. Sarkkinen E, Korhonen M, Erkkila A, Ebeling T, Uusitupa M. Effect of apolipoprotein E polymorphism on serum lipid response to the separate modification of dietary fat and dietary cholesterol. Am J Clin Nutr 1998;68:1215-22.
8. Weggemans RM, Zock PL, Ordovas JM, Pedro-Botet J, Katan MB. Apoprotein E genotype and the response of serum cholesterol to dietary fat, cholesterol and cafestol. Atherosclerosis 2001;154:547-55.
9. Martin LJ, Connelly PW, Nancoo D, Wood N, Zhang ZJ, Maguire G, et al. Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotype. J Lipid Res 1993;34:437-46.
10. Gylling H, Kontula K, Koivisto UM, Miettinen H, Miettinen TA. Polymorphisms of the genes encoding apoproteins A-I, B, C-III, and E and LDL receptor, and cholesterol and LDL metabolism during increased cholesterol intake. Arterioscler Thromb Vasc Biol 1997;17:38-44.
11. Glatz JFC, Demacker PNM, Turner PR, Katan MB. Response of serum cholesterol to dietary cholesterol in relation to apolipoprotein E phenotype. Nutr Metab Cardiovasc Dis 1991;1:13-17.
12. Heinemann T, Kullak-Ublick GA, Pietruck B, von Bergmann K. Mechanisms of action of plant sterols on inhibition of cholesterol absorption; Comparison of sitosterol and sitostanol. Eur J Clin Pharmacol: 1991;40(Suppl.1):s59-s63.
13. Vanhanen HT, Blomqvist S, Ehnholm C, Hyvönen M, Jauhiainen M, Torstila I, et al. Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apoE phenotypes during dietary sitostanol-ester treatment. J Lipid Res 1993;34:1535-44.
14. Plat J, Mensink RP. Vegetable oil based versus wood based stanol ester mixtures: effects on serum lipids and hemostatic factors in non hypercholesterolemic subjects. Atherosclerosis 2000;148:101-12.
15. Gylling H, Puska P, Vartiainen E, Miettinen TA. Serum sterols during stanol ester feeding in a mildly hypercholesterolemic population. J Lipid Res 1999;40:593-600.
16. Plat J, Mensink RP. Consumption of plant stanol esters increase LDL receptor expression in mononuclear cells from non-hypercholesterolemic subjects. Atherosclerosis 2000;151:86.
17. Miettinen TA, Tilvis RS, Kesäniemi YA. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 1990;131:20-31.
18. Kempen HJM, Glatz JFC, Gevers Leuven JA, van der Voort HA, Katan MB. Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J Lipid Res 1988;29:1149-55.
19. Plat J, Onselen van ENM, Mensink RP. Dietary plant stanol ester mixtures: effects on safety parameters and erythrocyte membrane fatty acid composition in non hypercholesterolemic subjects. Eur Heart J 1999;1(Suppl.):s58-s63.
20. Plat J, Mensink RP. Effects of diets enriched with two different plant stanol ester mixtures on plasma ubiquinol-10 and fat-soluble antioxidant concentrations. Metabolism 2001;50:520-9.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chtem 1972;18:499-502.
22. Hixson JE, Powers PK. Restriction isotyping of human apolipoprotein A-IV rapid typing of known isoforms and detection of a new isoform that deletes a conserved repeat. J Lipid Res 1991;32:1529-35.
23. Acton S, Osgood D, Donoghue M, Corella D, Pocovi M, Cenarro A, et al. Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol 1999;19:1734-43.
24. Kuivenhoven JA, de Knijff P, Boer JMA, Smalheer HA, Botma GJ, Seidell JC, et al. Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb Vasc Biol 1997;17:560-8.
25. Zuliani G, Hobbs HH. A high frequency of length polymorphisms in repeated sequences adjacent to Alu sequences. Am J Hum Genet 1990;46:963-9.
26. Abacus Concepts. Statview (for the Macintosh) Manual. Berkeley, CA: Abacus Concepts Inc.; 1992.
27. McCombs RJ, Marcadis DE, Ellis J, Weinberg RB. Attenuated hyper cholesterolemic response to a high-cholesterol diet in subjects heterozygous for the apolipoprotein A-IV-2 allele. N Engl J Med 1994;331:706-10.
28. Weggemans RM, Zock PL, Meyboom S, Funke H, Katan MB. Apolipoproten A4-1/2 polymorphism and response of serum lipids to dietary cholesterol in humans. J Lipid Res 2000;41:1623-8.
29. Weggemans RM. Genetic disposition and response of blood lipids to diet. Studies on gene-diet interaction in humans. Thesis. Wageningen University; 2001.
30. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs H, Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996;271:518-20.
31. Kozarsky KF, Donahee MH, Rigotti A, Iqbal SN, Edelman ER, Krieger M. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 1997;387:414-17.
32. Sehayek E, Ono JG, Shefer S, Nguyen LB, Wang N, Batt AK, et al. Biliary cholesterol excretion: a novel mechanism that regulates dietary cholesterol absorption. Proc Natl Acad Sci USA 1998;95:10194-9.
33. Hauser H, Dyer JH, Nandy A, Vega MA, Werder M, Bieliauskaite E, et al. Identification of a receptor mediating absorption of dietary cholesterol in the intestine. Biochemistry 1998;37:17843-50.
34. n repeat polymorphism in the HMG-CoA reductase gene and cholesterolemia. VASA 1999;28:169-71.
35. Dachet C, Poirier O, Cambien F, Chapman J, Rouis M. New functional promotor polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels - role of Sp1/Sp3 in transcriptional regulation. Arterioscler Thromb Vasc Biol 2000;20:507-15.
36. Lehtimaki T, Moilannen T, Viikari J, Akerblom HK, Ehnholm C, Ronnemaa T, et al. Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. J Lipid Res 1990;31:487-95.
37. Gylling H, Miettinen TA. Cholesterol absorption and synthesis related to low density lipoprotein metabolism during varying cholesterol intake in men wiith different apoE phenotypes. J Lipid Res 1992;33:1361-71.
38. Hallikainen MA, Sarkkinen ES, Uusitupa MI. Plant stanol esters affect serum cholesterol concentrations of hypercholesterolemic men and women in a dose-dependent manner. J Nutr 2000;130:767-76.
39. Clee SM, Zwinderman AH, Engert JC, Zwarts KY, Molhuizen HOF, Roomp K, et al. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 2001;103:1198-205.
40. Lutucuta S, Ballantyne CM, Elghannam H, Gotto AM, Marian AJ. Novel polymorphisms in promotor region of ATP binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ Res 2001;88:969-73.
41. Law M. Plant sterol and stanol margarines and health. BMJ 2000;320:861-4.
42. Neil HAW, Meijer GW, Roe LS. Randomised controlled trial of use by hypercholesterolaemic patients of a vegetable oil sterol-enriched fat spread. Atherosclerosis 2001;156:329-37.